Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neurolens
AddedFeb 15, 2024
UpdatedJun 18, 2026
Neurolens

Neurolens

Series D

Neurolens designs innovative prescription lenses with contoured prisms for eye alignment.

HQ
Coppell, TX, US
Founded
2012
Overview
Compare
Fundraising
Employees

Neurolens designs innovative prescription lenses with contoured prisms to bring the eyes into alignment, aiming to alleviate symptoms like headaches, neck pain, and eye strain. Their core mission is to enhance visual comfort and improve quality of life through advanced optical solutions, targeting individuals with digital eye strain and misalignment issues.

Neurolens has made significant strides in the optical industry, gaining recognition for its unique approach to vision correction. Their lenses have been adopted by numerous eye care professionals, contributing to improved patient outcomes. The company's impact is reflected in the growing number of satisfied users who experience relief from chronic discomfort.

Neurolens - Similar Companies

Lensabl logo

Lensabl

lensabl.com

Synergeyes logo

Synergeyes

synergeyes.com

EnChroma logo

EnChroma

enchroma.com

OptometRx logo

OptometRx

Eyes 4 Lives logo

Eyes 4 Lives

ReaLens logo

ReaLens

Laforge Optical logo

Laforge Optical

Adaptilens logo

Adaptilens

adaptilens.com

Hubble Contacts logo

Hubble Contacts

hubblecontacts.com

Eyelation logo

Eyelation

eyelation.com

Glassesusa.Com logo

Glassesusa.Com

glassesusa.com

JetLenses logo

JetLenses

Ophthonix logo

Ophthonix

Bausch & Lomb logo

Bausch & Lomb

bausch.com

ReVision Optics logo

ReVision Optics

revisionoptics.com

Neurolens - Quick Facts

Who are Neurolens' competitors?

Companies similar to Neurolens include Lensabl, Synergeyes, EnChroma and OptometRx.

When was Neurolens founded?

Neurolens was founded in 2012.

Where is Neurolens' headquarters located?

Neurolens' headquarters is located in Coppell, TX, US.

When was Neurolens' last funding round?

Neurolens' most recent funding round was for $45M (USD) in December 2023.

How much has Neurolens raised to-date?

As of Dec 5, 2023, Neurolens has raised a total of $186.5M (USD).

How many employees does Neurolens have?

Neurolens has 154 employees as of Feb 5, 2024.

Neurolens - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Prescription Lenses
Tags
  • Healthtech
NAICS
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339115Ophthalmic Goods Manufacturing
  • 330000Manufacturing
  • 339000Miscellaneous Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3827Optical Instruments And Lenses
Show 6 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified